Recent Finacing
Recent Raise
Intarcia Therapeutics is a Boston-based biopharmaceutical company leveraging its Medici continuous drug-delivery platform to develop therapies such as ITCA 650 for type 2 diabetes and a planned anti-HIV prophylactic implant.
